Lilly(US:LLY) Zheng Quan Ri Bao·2026-02-13 07:43Core Viewpoint - The "Early Appointment, Memory Protection" Alzheimer's Disease Popular Science Creative Competition has been launched, aiming to promote early detection, diagnosis, and treatment of Alzheimer's disease through creative and easily disseminated scientific expression [2][3]. Group 1: Competition Overview - The competition is organized by Eli Lilly in collaboration with Tsinghua University, focusing on reducing public misconceptions about Alzheimer's disease and enhancing understanding of new diagnostic and treatment technologies [2][3]. - It encourages participation from students at various academic levels and promotes intergenerational dialogue by inviting participants aged 55 and above to collaborate on projects [3]. Group 2: Objectives and Goals - The competition aims to transform the scientific concept of early intervention into accessible knowledge that can help patients receive timely treatment and support families in facing the future [3][4]. - Eli Lilly has invested $11 billion over nearly 40 years in Alzheimer's research and innovation, emphasizing its commitment to public education and volunteer services related to the disease [4]. Group 3: Evaluation and Impact - The evaluation criteria for submissions will include scientific accuracy, creativity, communicability, emotional resonance, and compliance [3]. - The competition is expected to enhance public scientific literacy and explore innovative communication pathways, contributing to the establishment of a dementia-friendly society in China [4].